MarketPeel
Insider Trading Intelligence
Pricing
…
NN

Nur Nicholson

APLS
CHIEF TECHNICAL OFFICER · APELLIS PHARMACEUTICALS, INC. · CIK 0001827317
FILING MIX · LIFETIME36%/64%
BUYS
20
SELLS
35
TOTAL VALUE
$8.29M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
0
AVG SELL PX
$42.14
TRADE KIND
SHOWING 55 / 55
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Nur Nicholson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+53.85%-0.24%+0.62%-0.87%-1.70%—
14d13+38.46%-1.09%+0.59%-1.68%+0.26%—
30d13+61.54%-2.21%+0.61%-2.82%-3.77%—
60d13+84.62%-14.32%-0.11%-14.22%-15.26%—
90d13+61.54%+6.04%+1.33%+4.71%-27.56%—
180d13(3 pending)+80.00%-24.25%+10.79%-35.05%-39.19%—
1y13(3 pending)+100.00%-40.98%+20.18%-61.16%-59.20%—
2y13(6 pending)+100.00%-62.47%+42.83%-105.30%-102.34%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APLS · 0 shares · as of May 14, 2026
029,08558,16987,254116,33820222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 35 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,250——41,250May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,284——24,284May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
82,500——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
50,974——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
9,754——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
5,645——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
35,472——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
45,000——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
28,367——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
41,250——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,610——22,610May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
27,320——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
116,338——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
22,610——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
115,281——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
24,284——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
45,220——45,220May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
45,220——0May 14, 2026May 14, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
45,220——116,338Jan 28, 2026Jan 30, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
7,725$21.77$168.1K71,118Jan 22, 2026Jan 23, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,203$19.79$43.6K78,843Jan 20, 2026Jan 21, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,618$22.19$58.1K81,046Jan 13, 2026Jan 15, 2026 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
82,500$19.39$1.60M82,500Jun 9, 2025Jun 11, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
825$29.52$24.4K83,664Jan 29, 2025Jan 30, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
3,948$30.43$120.1K84,489Jan 22, 2025Jan 23, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,426——88,437Jan 21, 2025Jan 21, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,145$29.96$64.3K52,011Jan 17, 2025Jan 21, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,632$28.70$75.5K54,156Jan 13, 2025Jan 14, 2025 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
7,768$57.31$445.2K59,739Mar 13, 2024Mar 14, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
3,452$58.13$200.7K56,287Mar 13, 2024Mar 14, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
835$64.14$53.6K67,507Jan 29, 2024Jan 31, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,593$65.00$168.5K68,342Jan 22, 2024Jan 23, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
1,857$66.81$124.1K70,935Jan 16, 2024Jan 17, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
28,367$66.30$1.88M28,367Jan 16, 2024Jan 17, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,508——72,792Jan 16, 2024Jan 17, 2024 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
10,631$46.15$490.6K53,284Sep 18, 2023Sep 19, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
9,719——115,281Sep 18, 2023Sep 19, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASE
Chief Technical Officer
9,719$29.76$289.2K73,634Sep 18, 2023Sep 19, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
9,719$42.21$410.2K63,915Sep 18, 2023Sep 19, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,023——14,023Feb 21, 2023Feb 21, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
825$58.50$48.3K63,503Feb 21, 2023Feb 21, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
9,886——64,328Feb 21, 2023Feb 21, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
551$52.77$29.1K54,442Jan 27, 2023Jan 30, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
2,034$52.05$105.9K54,993Jan 20, 2023Jan 24, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,580——57,027Jan 12, 2023Jan 17, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,472$52.66$1.87M35,472Jan 12, 2023Jan 17, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
1,875——33,680Apr 25, 2022Jan 17, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
11,250——0Apr 25, 2022Jan 17, 2023 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
SALE
Chief Technical Officer
650$38.59$25.1K35,555Jan 28, 2022Jan 31, 2022 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,951——36,951Jan 21, 2022Jan 25, 2022 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,051——36,205Jan 21, 2022Jan 25, 2022 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Jan 28, 2021Jan 29, 2021 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,500——7,500Jan 28, 2021Jan 29, 2021 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,875——9,375Jan 28, 2021Jan 29, 2021 ↗View →
APLS
APELLIS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
11,250——11,250Jan 28, 2021Jan 29, 2021 ↗View →
Other insiders · APLS
Loading peer insiders…
About this filer
CIK 0001827317
ROLE
Chief Technical Officer
PRIMARY
APLS
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001827317DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback